NSTEMI non-ST-segment elevation myocardial infarction UA unstable angina DVT deep venous thrombosis PE pulmonary embolism SAH subarachnoid hemorrhage ET-1 endothelin-1 ALI acute lung injury ARDS acute respiratory distress syndrome SI-ALI smoke inhalation with acute lung injury NS nephrotic syndrome DN di...
SEX-RELATED \{EFFECTIVENESS\} \{OF\} \{BIVALIRUDIN\} \{VERSUS\} \{ABCIXIMAB\} \{AND\} \{HEPARIN\} \{IN\} NSTEMI: \{LESSONS\} \{FROM\} \{THE\} \{INTRACORONARY\} \{STENTING\} \{AND\} \{ANTITHROMBOTIC\} REGIME: \{RAPID\} \{EARLY\} \{ACTION\} \{FOR\} \{CORONARY\} \{...
Abciximab/heparin vs bivalirudin for NSTEMI: ISAR-REACT 4 trial – 1 yearAbciximab/heparin vs bivalirudin for NSTEMI ISARREACT trialEurointervention
Based on these results suggesting a better benefit-to-risk ratio over enoxaparin, the European Society of Cardiology recommended fondaparinux as the first-line anticoagulation therapy in patients with an NSTEMI in 2007. A registry study conducted in Sweden provides real-life cli...
Testing for COVID was not routinely performed. Pre-specified analyses in patients with STEMI, NSTEMI and Stable angina were undertaken. RESULTS. Of 1227 PCI procedures performed over the period of observation, 690 were pre-pandemic and 537 were afterwards. Overall median heparin dose per case was...